À retenir
Among 17 141 survivors of seven cancers in six pooled cohorts, more moderate-to-vigorous activity after diagnosis was linked to lower cancer mortality, for example HR 0.56 for lung cancer survivors doing a little activity versus none. This is observational, and illness may reduce activity as well as the reverse.
Study design
Article de recherche
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Exercise is linked to longer survival in some cancers, but evidence is thin for less commonly studied ones. The authors asked whether leisure-time physical activity after diagnosis, and changes in activity from before to after diagnosis, relate to cancer death in seven such cancers.
Population et méthode
Pooled analysis of six US cohorts (Cancer Prevention Study-II Nutrition Cohort, Health Professionals Follow-Up Study, NIH-AARP Diet and Health Study, Nurses' Health Study, Nurses' Health Study II, Women's Health Study), with baseline data from 1976 through 1997. Participants were survivors of bladder, endometrial, kidney, lung, oral cavity, ovarian or rectal cancer with repeated self-reported leisure-time moderate to vigorous physical activity (MVPA), measured before and a mean of 2.8 years after diagnosis, in MET-hours per week. Mean follow-up was 10.9 years; outcome was cancer mortality (hazard ratios).
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1The analysis included 17 141 survivors (mean age 67 years; 60% female).
- 2Low MVPA (more than 0 to under 7.5 versus 0 MET-h/wk) was linked to lower cancer mortality in bladder (HR 0.67; 95% CI 0.50-0.91), endometrial (HR 0.62; 0.45-0.87) and lung cancer survivors (HR 0.56; 0.43-0.75).
- 3At around double the guideline amount or more, mortality was lower in oral cancer (HR 0.39; 0.15-0.99 at more than 22.5 to 30.0 MET-h/wk) and rectal cancer (HR 0.57; 0.33-0.97 at more than 15.0 to 22.5 MET-h/wk) survivors. For kidney cancer the HR was 0.51 (0.22-1.18), a confidence interval that includes no effect.
- 4Compared with survivors not meeting guidelines before or after diagnosis, lung (HR 0.58; 0.47-0.71) and rectal (HR 0.51; 0.32-0.83) survivors who met guidelines after diagnosis had lower cancer mortality, even if inactive beforehand.
Limites et incertitude
- 1Activity was self-reported on surveys, and people who are sicker may exercise less (reverse causation), so the link may not mean activity extended survival.
- 2Several cancer types had few participants, as the wide intervals show (for example 0.15-0.99 for oral cancer), and results across many activity categories and cancers raise the chance of chance findings.
- 3Baseline data date from 1976 through 1997, and activity was measured on average 2.8 years after diagnosis, so treatment-era and timing differences matter.
- 4This reading is based on the abstract only.
Mise en perspective
Staying or becoming active after a cancer diagnosis is associated with lower cancer mortality, even at modest amounts, and starting after diagnosis seemed to help in lung and rectal survivors. This does not show that exercise caused longer survival, and what is safe depends on your treatment and condition, so plan activity with your oncology team.
Vos données
Weekly minutes of moderate and vigorous activity from a wearable or log map onto the MVPA measure used here. Track the weekly trend on the same device rather than any single day, and share it with your care team.
Comprendre ce type de preuve
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Importance
There is insufficient evidence to determine whether physical activity lengthens survival among people with a history of cancers less commonly studied for such benefit.
Objective
To examine the associations between physical activity assessed after a cancer diagnosis with cancer mortality and, secondarily, changes in physical activity before vs after diagnosis with cancer mortality among people previously diagnosed with 1 of 7 cancers.
Design, setting, and participants
This study used a pooled dataset of 6 cohorts (Cancer Prevention Study-II Nutrition Cohort, Health Professionals Follow-Up Study, National Institutes of Health-AARP Diet and Health Study, Nurses' Health Study, Nurses' Health Study II, and Women's Health Study). Participants were survivors of bladder, endometrial, kidney, lung, oral cavity, ovarian, or rectal cancer who had completed surveys and had repeated measures of leisure-time physical activity. Baseline data were collected from 1976 through 1997. The mean (SD) follow-up was 10.9 (7.0) years. Data were analyzed from June 2023 to March 2024.
Exposures
Leisure-time moderate to vigorous physical activity (MVPA) before and after cancer diagnosis.
Main outcomes and measures
Association of MVPA in categories of metabolic equivalents of task hours per week (MET-h/wk) measured before and a mean (SD) of 2.8 (1.5) years after cancer diagnosis with cancer mortality.
Results
This pooled analysis included 17 141 cancer survivors (mean [SD] age, 67 [8] years; 60% female). Engagement in low amounts of MVPA (>0 to <7.5 vs 0 MET-h/wk) was associated with lower risk of cancer mortality among survivors who had been diagnosed with bladder (hazard ratio [HR], 0.67 [95% CI, 0.50-0.91]), endometrial (HR, 0.62 [95% CI, 0.45-0.87]), and lung cancer (HR, 0.56 [95% CI, 0.43-0.75]). Doubling the recommended MVPA guideline or more (eg, >15 vs 0 MET-h/wk) was associated with lower risk of cancer mortality among oral (HR, 0.39 [95% CI, 0.15-0.99] for >22.5 to 30.0 MET-h/wk) and rectal (HR, 0.57 [95% CI, 0.33-0.97] for >15.0 to 22.5 MET-h/wk) cancer survivors. Point estimates were less than 1 for cancer mortality among kidney cancer survivors (HR, 0.51 [95% CI, 0.22-1.18] for >15.0 to 22.5 MET-h/wk), although the confidence interval included the null. Compared with survivors who did not meet the MVPA guidelines before or after diagnosis, lung (HR, 0.58 [95% CI, 0.47-0.71]) and rectal (HR, 0.51 [95% CI, 0.32-0.83]) cancer survivors who met guidelines after diagnosis had a lower risk of cancer mortality, even if they were inactive before their diagnosis.
Conclusions and relevance
In this analysis of 6 pooled cohorts, higher levels of MVPA after a cancer diagnosis were associated with lower risk of cancer mortality among people previously diagnosed with 1 of 7 cancers not commonly studied for their association with MVPA. Findings suggest that it is important for health care professionals to promote physical activity for longevity and overall health among people living with and beyond cancer.
Sources et attribution
Leisure-Time Physical Activity and Cancer Mortality Among Cancer Survivors.
Rees-Punia E, Teras LR, Newton CC, Moore SC, Lee IM, Bates-Fraser L, Chiang KE, Bloodworth DE, Eliassen AH, Mucci L, Lynch BM, Stampfer M, Song M, Brantley KD, Stopsack KH, Matthews CE, Patel AV.
JAMA network open · 2026-02-02
DOI: 10.1001/jamanetworkopen.2025.56971 ↗PubMed · 41701497 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
The Lancet Public Health
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ

